Submit

Curis Lifesciences IPO

Mainboard

Issue Open Nov 07, 2025
Issue Close Nov 11, 2025
Price Band ₹ 120 to ₹ 128 per share
Face Value Rs 10/- per share
Issue Size 27.52 Cr
Listing Exchange NSE SME
Issue Type Book build offer
Cut off time for UPI Mandate Confirmation Nov 11, 2025 05:00 PM
Allotment Details Nov 12, 2025
Refunds Nov 13, 2025
Credit of Shares to Demat Nov 13, 2025
Listing On Nov 14, 2025
About the company:

Curis Lifesciences Ltd. is a leading pharmaceutical manufacturer specializing in the production of tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. Based in Sanand, Gujarat, the company operates with advanced WHO-GMP-certified facilities and has approvals from global regulatory bodies, including PPB Kenya, MOH Yemen, FDA Philippines, and NAFDAC Nigeria. Curis Lifesciences follows a diversified business model encompassing loan license manufacturing, contract manufacturing, and direct exports under its own brands, catering to over 100 clients worldwide. Its expertise in custom formulation, quality assurance, and global compliance enables it to serve both domestic and international markets across regions such as Africa, Asia, and Europe. With a strong focus on innovation, scalability, and adherence to international standards, Curis Lifesciences continues to build trust as a reliable pharmaceutical partner delivering safe, effective, and high-quality healthcare products for global well-being.

FAQ’s

Can I trade an IPO through a Discount Broker?

What are the benefit of buying & selling IPOs through a discount broker?

How is it possible to trade an IPO through a discount broker when SEBI has made mandatory to buy an IPO through ASBA?

How can I buy and sell IPO through a discount broker?

What documents are required to open an account with Samco?

Open Free Account Now

Open Free Trading & Demat Account

+91